Bydureon Bcise

Physical Activity, Type 2 Diabetes, Diet
Treatment
0 Active Studies for Bydureon Bcise

What is Bydureon Bcise

ExenatideThe Generic name of this drug
Treatment SummaryExenatide is a medication used to control blood sugar levels. It works by activating the GLP-1 receptor, which increases insulin secretion, lowers glucagon secretion, and slows digestion. Exenatide was approved by the FDA in 2005.
Byettais the brand name
image of different drug pills on a surface
Bydureon Bcise Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Byetta
Exenatide
2005
10

Effectiveness

How Bydureon Bcise Affects PatientsExenatide helps the body to better regulate its response to glucose. This means when glucose is present, insulin is released in the right amount and glucagon is released in a lower amount. During hypoglycemia, the normal amount of glucagon is still released. Additionally, exenatide slows down how quickly the stomach empties, leading to a slower and more controlled release of glucose into the body. These effects help to prevent both high and low blood sugar levels.
How Bydureon Bcise works in the bodyExenatide is a drug that helps control blood sugar levels. It does this by activating a certain receptor in the body, which then increases the production of insulin and decreases the production of glucagon. These hormones help regulate glucose levels in the body. Exenatide also slows down how quickly food leaves the stomach, which helps keep blood sugar levels steady. All of these effects work together to help prevent both high and low blood sugar.

When to interrupt dosage

The recommended quantity of Bydureon Bcise relies upon the diagnosed situation. The degree of dosage fluctuates, in light of the administration method delineated in the table below.
Condition
Dosage
Administration
Physical Activity
, 0.25 mg/mL, 0.005 mg, 0.01 mg, 2.0 mg, 20.0 mg/mL, 2.0 mg/dose, 0.005 mg/pump actuation, 0.01 mg/pump actuation
, Subcutaneous, Injection, Injection - Subcutaneous, Kit, Injection, solution, Injection, solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, for suspension, extended release - Subcutaneous, Solution, Solution - Subcutaneous, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Subcutaneous, Injection, suspension, extended release, Injection, suspension, extended release - Subcutaneous, Suspension, extended release, Suspension, extended release - Subcutaneous
Type 2 Diabetes
, 0.25 mg/mL, 0.005 mg, 0.01 mg, 2.0 mg, 20.0 mg/mL, 2.0 mg/dose, 0.005 mg/pump actuation, 0.01 mg/pump actuation
, Subcutaneous, Injection, Injection - Subcutaneous, Kit, Injection, solution, Injection, solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, for suspension, extended release - Subcutaneous, Solution, Solution - Subcutaneous, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Subcutaneous, Injection, suspension, extended release, Injection, suspension, extended release - Subcutaneous, Suspension, extended release, Suspension, extended release - Subcutaneous
Diet
, 0.25 mg/mL, 0.005 mg, 0.01 mg, 2.0 mg, 20.0 mg/mL, 2.0 mg/dose, 0.005 mg/pump actuation, 0.01 mg/pump actuation
, Subcutaneous, Injection, Injection - Subcutaneous, Kit, Injection, solution, Injection, solution - Subcutaneous, Injection, powder, for suspension, extended release, Injection, powder, for suspension, extended release - Subcutaneous, Solution, Solution - Subcutaneous, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Subcutaneous, Injection, suspension, extended release, Injection, suspension, extended release - Subcutaneous, Suspension, extended release, Suspension, extended release - Subcutaneous

Warnings

Bydureon Bcise Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Exenatide may interact with Pulse Frequency
There are 20 known major drug interactions with Bydureon Bcise.
Common Bydureon Bcise Drug Interactions
Drug Name
Risk Level
Description
(R)-warfarin
Moderate
Exenatide can cause an increase in the absorption of (R)-warfarin resulting in an increased serum concentration and potentially a worsening of adverse effects.
(S)-Warfarin
Moderate
Exenatide can cause an increase in the absorption of (S)-Warfarin resulting in an increased serum concentration and potentially a worsening of adverse effects.
2,4-thiazolidinedione
Moderate
The risk or severity of hypoglycemia can be increased when Exenatide is combined with 2,4-thiazolidinedione.
4-hydroxycoumarin
Moderate
Exenatide can cause an increase in the absorption of 4-hydroxycoumarin resulting in an increased serum concentration and potentially a worsening of adverse effects.
AICA ribonucleotide
Moderate
The risk or severity of hypoglycemia can be increased when Exenatide is combined with AICA ribonucleotide.
Bydureon Bcise Toxicity & Overdose RiskAnimal studies have shown that exenatide use during pregnancy can cause deformities in the baby’s ribs and vertebrae and slow growth. Uncontrolled high blood sugar during pregnancy has been linked to a 25% risk of miscarriage. There are no known human studies on the effects of exenatide in pregnancy and it should only be prescribed if the benefits outweigh the risks. It is not known how exenatide affects breastfed infants or pediatric patients, so the risks and benefits should be weighed carefully. Older adults may be more likely to experience side effects due to their higher risk of renal impairment or other health issues,
image of a doctor in a lab doing drug, clinical research

Bydureon Bcise Novel Uses: Which Conditions Have a Clinical Trial Featuring Bydureon Bcise?

162 active trials are currently being conducted to assess the potential of Bydureon Bcise in providing relief for Type 2 Diabetes.
Condition
Clinical Trials
Trial Phases
Type 2 Diabetes
169 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4, Early Phase 1
Diet
6 Actively Recruiting
Not Applicable
Physical Activity
43 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Early Phase 1

Bydureon Bcise Reviews: What are patients saying about Bydureon Bcise?

4.7Patient Review
1/22/2020
Bydureon Bcise for Type 2 Diabetes Mellitus
I've been using this product for six months now, and I'm really happy with it. The pens have been working great (no problems there), and the side effects weren't too bad once my body got used to the medication. Just be careful with what you eat; if you overdo it, you'll feel pretty sick. In just 90 days, my A1C went from 9.4 to 7.2, which is amazing!
4.3Patient Review
2/4/2019
Bydureon Bcise for Type 2 Diabetes Mellitus
After a few weeks of taking this medication, I really noticed an improvement in my condition. The injector is easy to use and painless, which is great. A common side effect that I experienced was bumps at the injection sight; however, they would go away after a couple of weeks and didn't cause any pain or discoloration.
3.3Patient Review
5/23/2019
Bydureon Bcise for Type 2 Diabetes Mellitus
I took this drug for three months and it worked great, A1C lowered to 6.6 and I found it easy to use. Once shaken, you could see it going in, so no problem with injection. the fourth month I developed severe gas and bloating, quickly followed by nausea, vomiting and diarhhea. A miserable three days!
3.3Patient Review
11/7/2018
Bydureon Bcise for Type 2 Diabetes Mellitus
The injector is not great. It can squirt out when you remove the cap and it can fail to penetrate the skin because of the shroud around the needle. If you can get it injected, it seems to work though.
3.3Patient Review
6/9/2022
Bydureon Bcise for Type 2 Diabetes Mellitus
The injector is faulty; two out of the last three times I've used it, the medication hasn't been injected and has instead sprayed out. This wastes an expensive pen each time, which costs me over $100 out of pocket.
2.3Patient Review
4/30/2019
Bydureon Bcise for Type 2 Diabetes Mellitus
I tried this for 8 weeks and saw no results.
1.7Patient Review
10/4/2021
Bydureon Bcise for Type 2 Diabetes Mellitus
The design of this product is very poor. I have wasted three needles trying to unscrew the cap after unlocking and mixing. As soon as I try to remove the cap, the needle springs out and ejects the contents.
1.7Patient Review
11/11/2018
Bydureon Bcise for Type 2 Diabetes Mellitus
The injector is terrible. It often squirts out when you remove the cap, and it can fail to penetrate the skin. I can't believe they released this before testing it properly.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about bydureon bcise

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Bydureon BCise for?

"BYDUREON BCise is an injectable medicine that can help improve blood sugar levels in adults and children 10 years of age and older with type 2 diabetes mellitus. It should be used along with a healthy diet and exercise plan."

Answered by AI

Is Trulicity and Bydureon the same?

"Both Bydureon and Trulicity are in the same class of medication, meaning they work in the same way to improve blood sugar levels in people with type 2 diabetes."

Answered by AI

Is Bydureon considered insulin?

"No, Bydureon does not increase the amount of insulin in your body, but it does make your body release more insulin. Is Bydureon used for weight loss? No. Bydureon is not used for weight loss, even though weight loss is a common side effect."

Answered by AI

What is the difference between Bydureon pen and Bydureon BCise?

"Bydureon BCise is designed to be easy and convenient for patients to use. It only needs to be mixed for 15 seconds, compared to the Bydureon Pen which must be tapped 80 times or more to make sure the medicine is well mixed."

Answered by AI